MADRIGAL PHARMACEUTICALS, INC.

MDGLNasdaq· Pharmaceutical Preparations

Price History

Revenue

$958.4M

▲ 432.1% YoY

Net Income

-$288.3M

▲ 38.1% YoY

EPS

$-12.85

▲ 41.3% YoY

Cash

$198.7M

▲ 98.7% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.